Volume 146, Issue 3, Pages (September 2017)

Slides:



Advertisements
Similar presentations
Differential drug responses of circulating tumor cells within patient blood Andrew D. Hughes, Jocelyn R. Marshall, Eric Keller, John D. Powderly, Bryan.
Advertisements

Nicoletta Colombo, Martin Gore 
Volume 144, Issue 1, Pages (January 2017)
Volume 34, Issue 4, Pages (August 2015)
Volume 64, Issue 3, Pages (September 2013)
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC)  Giorgio Arcangeli,
Critical Reviews in Oncology / Hematology
Perri Carlson, Kathryn Nicholson Perry 
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.
The importance of dose in land-based supervised exercise for people with hip osteoarthritis. A systematic review and meta-analysis  T. Moseng, H. Dagfinrud,
Effectiveness of low-level laser therapy in patients with knee osteoarthritis: a systematic review and meta-analysis  Z. Huang, J. Chen, J. Ma, B. Shen,
Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Breast Care 2016;11: DOI: / Fig. 1. Strategies.
Volume 150, Issue 1, Pages (July 2018)
Clinical and Translational Radiation Oncology
Volume 148, Issue 1, Pages (January 2018)
Are patients willing to travel for better ovarian cancer care?
Volume 69, Issue 4, Pages (April 2016)
Volume 148, Issue 1, Pages (January 2018)
Volume 149, Issue 2, Pages (May 2018)
Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis  V. Silverwood, M. Blagojevic-Bucknall,
Angel Lanas, Ping Wu, Jennie Medin, Edward J. Mills 
Vulvar intraepithelial neoplasia: Risk factors for recurrence
Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas.
Volume 141, Issue 1, Pages 2-9 (April 2016)
Supplemental oxygen and surgical site infection: getting to the truth
Volume 144, Issue 2, Pages (February 2017)
Effect of combining tramadol and morphine in adult surgical patients: a systematic review and meta-analysis of randomized trials  V. Martinez, L. Guichard,
M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns
Volume 151, Issue 1, Pages (October 2018)
Wilberto Nieves-Neira, J. Julie Kim, Daniela Matei 
Volume 136, Issue 2, Pages (February 2015)
Volume 130, Issue 3, Pages (September 2013)
Volume 142, Issue 3, Pages (September 2016)
National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence  J. Chino, J.R. Foote,
Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer  E.N. Prendergast,
Volume 151, Issue 1, Pages (October 2018)
K. Bixel, N. Denlinger, L. Marsh, A. Quick, R. Salani
Volume 147, Issue 2, Pages (November 2017)
Volume 152, Issue 1, Pages (January 2019)
Volume 143, Issue 2, Pages (November 2016)
Laparoscopic staging for stage I epithelial ovarian cancer: Analysis of the National Cancer Data Base  A. Melamed, J.T. Clemmer, N.L. Keating, J.D. Wright,
The origins of multidisciplinary cancer care
Adherence to hematologic hold parameters in dose-dense chemotherapy for ovarian malignancies: A survey of the National Comprehensive Cancer Network (NCCN)
Comparing the health and economic impacts of cervical cancer screening strategies using the Cancer Risk Management Model (CRMM)  C. Popadiuk, A.J. Coldman,
I. Mert, A. R. Munkarah, R. K. Hanna, J. Chhina, M. S. Carey, M
Survivors' acceptance of treatment side effects evolves as goals of care change over the cancer continuum  A. Ellis, M.K. Frey, L.M. Koontz, S. Shyne,
Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.
Volume 13, Issue 9, Pages (September 2012)
Are ovarian cancer debulking models reliable: Variance and predictability are dependent on institutional optimal debulking rates  N.A. Latif, E.M. Ko,
Volume 147, Issue 1, Pages (October 2017)
Vaccinations against respiratory tract infections at Hajj
The complex interaction of cancer surgery, complications, and patient-reported outcomes: A single score is not enough  K.M. Doll, E.L. Barber, J.T. Bensen,
Volume 142, Issue 2, Pages (August 2016)
Annika Idahl, Andrea Hermansson, Ann Lalos  Gynecologic Oncology 
Volume 147, Issue 3, Pages (December 2017)
Volume 150, Issue 3, Pages (September 2018)
Volume 152, Issue 1, Pages (January 2019)
Volume 152, Issue 1, Pages (January 2019)
Volume 130, Issue 3, Pages (September 2013)
Volume 151, Issue 1, Pages (October 2018)
Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,
Regional anaesthesia to prevent chronic pain after surgery: a Cochrane systematic review and meta-analysis†  M.H. Andreae, D.A. Andreae  British Journal.
Does anaesthesia with nitrous oxide affect mortality or cardiovascular morbidity? A systematic review with meta-analysis and trial sequential analysis 
Volume 147, Issue 3, Pages (December 2017)
High-risk cancer, unequal care: Disparities in the complete surgical staging of high- grade endometrial cancer in the Southeastern United States  J.R.
Should ovarian preservation be considered for women younger than 60 years with endometrial carcinoma?  L.M. Bean, K. Taylor, K.M. Anderson, M.A. Davis,
Volume 154, Issue 1, Pages (July 2019)
Michael Yan, Weidong Kong, Andrew Kerr, Michael Brundage 
Volume 154, Issue 1, Pages (July 2019)
Presentation transcript:

Volume 146, Issue 3, Pages 504-513 (September 2017) Clinical benefit and risk of death with endocrine therapy in ovarian cancer: A comprehensive review and meta-analysis  Laura Paleari, Sara Gandini, Nicoletta Provinciali, Matteo Puntoni, Nicoletta Colombo, Andrea DeCensi  Gynecologic Oncology  Volume 146, Issue 3, Pages 504-513 (September 2017) DOI: 10.1016/j.ygyno.2017.06.036 Copyright © 2017 The Authors Terms and Conditions

Fig. 1 Flow diagram of study search and selection. Gynecologic Oncology 2017 146, 504-513DOI: (10.1016/j.ygyno.2017.06.036) Copyright © 2017 The Authors Terms and Conditions

Fig. 2 Forest plot of the association between endocrine therapy by type of drug and summary clinical benefit rate (SCBR) in ovarian cancer. Gynecologic Oncology 2017 146, 504-513DOI: (10.1016/j.ygyno.2017.06.036) Copyright © 2017 The Authors Terms and Conditions

Fig. 3 Forest plot of the association between endocrine therapy by hormone receptors status and summary clinical benefit rate (SCBR) in ovarian cancer. Gynecologic Oncology 2017 146, 504-513DOI: (10.1016/j.ygyno.2017.06.036) Copyright © 2017 The Authors Terms and Conditions

Fig. 4 Forest plot of the association between endocrine therapy by responsiveness to platinum-based chemotherapy and summary clinical benefit rate (SCBR) in ovarian cancer. Gynecologic Oncology 2017 146, 504-513DOI: (10.1016/j.ygyno.2017.06.036) Copyright © 2017 The Authors Terms and Conditions

Fig. 5 Forest plot of the association between endocrine therapy and summary estimate for death risk stratified by first line regimen. Gynecologic Oncology 2017 146, 504-513DOI: (10.1016/j.ygyno.2017.06.036) Copyright © 2017 The Authors Terms and Conditions

Fig. 6 Forest plot of the association between endocrine therapy and summary estimate for death risk stratified by tumor grade. Gynecologic Oncology 2017 146, 504-513DOI: (10.1016/j.ygyno.2017.06.036) Copyright © 2017 The Authors Terms and Conditions

Supplementary Fig. 1 Forest plot of the association between endocrine therapy by tamoxifen dose and summary clinical benefit (SCBR) in ovarian cancer. Gynecologic Oncology 2017 146, 504-513DOI: (10.1016/j.ygyno.2017.06.036) Copyright © 2017 The Authors Terms and Conditions